
Will Palantir Stock Split?
Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $180B | $195.2B | $244.3B | $51.1B | $65.6B | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | $21.42 | $17.39 | $12.24 | $3.49 | $5.13 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $28.9B | $26.1B | $29.5B | $32.4B | -- | |
Total Assets | $155.5B | $154.9B | $143.9B | $152.8B | -- | |
Current Liabilities | $30.7B | $31.8B | $35.8B | $41.1B | -- | |
Total Liabilities | $105.1B | $107.7B | $99.1B | $106.4B | -- | |
Total Equity | $50.4B | $47.2B | $44.8B | $46.4B | -- | |
Total Debt | $32.9B | $33.7B | $31.1B | $30.9B | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $10.8B | $12.4B | $6.6B | $2.8B | $46M | |
Cash From Investing | $3.8B | -$5.4B | -$2.4B | -$1.3B | -$776M | |
Cash From Financing | -$11B | -$5.7B | -$5.6B | -$2.6B | $439M | |
Free Cash Flow | $9.6B | $10.9B | $5.2B | $2.4B | -$353M |
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
In the current month, CI has received 13 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CI average analyst price target in the past 3 months is $362.31.
According to analysts, the consensus estimate is that The Cigna Group share price will rise to $362.31 per share over the next 12 months.
Analysts are divided on their view about The Cigna Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Cigna Group is a Sell and believe this share price will drop from its current level to $323.00.
The price target for The Cigna Group over the next 1-year time period is forecast to be $362.31 according to 18 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for The Cigna Group is a Buy. 13 of 18 analysts rate the stock a Buy at this time.
You can purchase shares of The Cigna Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Cigna Group shares.
The Cigna Group was last trading at $314.09 per share. This represents the most recent stock quote for The Cigna Group. Yesterday, The Cigna Group closed at $299.81 per share.
In order to purchase The Cigna Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last…
With a personal net worth of approximately $6.5 billion and…
The degree to which the healthcare paradigm has changed is…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 2.83% over the past day.
Hims & Hers Health [HIMS] is down 19.28% over the past day.
Vicor [VICR] is down 5.16% over the past day.